Standard Operating Procedures for Chinese Medicine Data Monitoring Committees of Clinical Studies.
10.1007/s11655-020-3439-2
- Author:
Jun LIU
1
;
Nian WANG
1
;
Hai-Xia DANG
2
;
Bing-Wei CHEN
3
;
Li ZHANG
4
;
Chong ZOU
5
;
Cheng-Liang ZHONG
6
;
Ju-Kai HUANG
4
;
Qiong LIU
1
;
Ya-Nan YU
1
;
Meng JIANG
5
;
Wei-Xiong LIANG
7
;
Qi-Guang CHEN
3
;
Yong-Yan WANG
1
;
Chun-Ti SHEN
8
;
Zhong WANG
9
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
2. China Academy of Chinese Medical Sciences, Beijing, 100700, China.
3. School of Public Health, Southeast University, Nanjing, 210009, China.
4. Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100078, China.
5. Jiangsu Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Nanjing University of Traditional Chinese Medicine), Nanjing, 210029, China.
6. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300381, China.
7. Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
8. Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu Province, 213004, China.
9. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China. zhonw@vip.sina.com.
- Collective Name:World Federation of Chinese Medicine Societies—Data Monitoring Committee for Clinical Studies
- Publication Type:Journal Article
- Keywords:
Chinese Medicine Data Monitoring Committee;
Chinese medicine;
clinical trial;
community standard;
data monitoring committee
- From:
Chinese journal of integrative medicine
2021;27(7):483-489
- CountryChina
- Language:English
-
Abstract:
Although there is guidance from different regulatory agencies, there are opportunities to bring greater consistency and stronger applicability to address the practical issues of establishing and operating a data monitoring committee (DMC) for clinical studies of Chinese medicine. We names it as a Chinese Medicine Data Monitoring Committee (CMDMC). A panel composed of clinical and statistical experts shared their experience and thoughts on the important aspects of CMDMCs. Subsequently, a community standard on CMDMCs (T/CACM 1323-2019) was issued by the China Association of Chinese Medicine on September 12, 2019. This paper summarizes the key content of this standard to help the sponsors of clinical studies establish and operate CMDMCs, which will further develop the scientific integrity and quality of clinical studies.
